<DOC>
	<DOC>NCT02626559</DOC>
	<brief_summary>Serum levels of bupivacaine over time after peri-articular injection of a mixture of liposomal bupivacaine and plain bupivacaine during total knee arthroplasty.</brief_summary>
	<brief_title>Serum Bupivacaine Concentration Levels After Injection of Liposomal Bupivacaine Into the Knee</brief_title>
	<detailed_description />
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Adults of at least 18 years of age having a primary, unilateral total knee arthroplasty with a surgical plan to have an intraarticular injection of a mixture of 266 mg of Exparel, 125 mg of bupivacaine, 1:300,000 epinephrine, and 0.9% saline to make a total volume of 100 ml. Known hepatic dysfunction or renal insufficiency (creatinine &gt; 1.5 mg/dL); allergy to the study medications; pregnancy; incarceration; inability to communicate with the investigators; morbid obesity (body mass index &gt; 40 kg/m2).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>